<HTML>
<HEAD>
<TITLE>AOD Thesaurus Annotated Hierarchy: biomedicine ED EE20.8.2.2</TITLE>
<META
Name="Description"sA Guide to Concepts and Terminology in Substance Abuse and Addiction">
</META>
<META
Name="Keywords"
Content="classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept">
</META>
</HEAD>
<body bgcolor="#FFFFFF">
<CENTER><B><BIG>AOD Thesaurus.&nbsp;&nbsp;Annotated Hierarchy.&nbsp;&nbsp;biomedicine.&nbsp;&nbsp;ED - EE20.8.2.2</BIG></B></Center>
<CENTER><A HREF="aodob.htm#E">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ED">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqe.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhne.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><BR><BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED"><B>ED</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>growth and development</B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ED"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD>+EG2e cell growth and differentiation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EAe general life processes &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EA"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EA"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EA22.6e biological repair &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EA22-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EA22-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EY10 heredity and evolution &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EY10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EY10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED2">ED2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>biological growth&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4">ED4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>biological development&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>When appropriate, use a more specific term, such as *+ED6.2 biological maturation* <A HREF="aodhqe.htm#ED6-2"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#ED6-2"><SMALL>ah</SMALL></A>, *+ED4.10
   prenatal development* <A HREF="aodhqe.htm#ED4-10"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#ED4-10"><SMALL>ah</SMALL></A>, *+ED4.10.2.2 embryogenesis* <A
   HREF="aodhqe.htm#ED4-10-2-2"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#ED4-10-2-2"><SMALL>ah</SMALL></A>, *ED4.10.4 fetal development* <A HREF="aodhqe.htm#ED4-10-4"><SMALL>qh</SMALL></A> <A
   HREF="aodhned.htm#ED4-10-4"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+FCe psychological development &nbsp;&nbsp;&nbsp;<A HREF="aodhqf.htm#FC"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnf.htm#FC"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-2">ED4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>neural development&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-4">ED4.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biological differentiation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD>+ED4.10.2.4 organogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ED4.10.2.2.8 gastrulation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-10-2-2-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-4-2">ED4.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>morphogenesis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD>+EG2.8e cell migration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EG6.6 cell aggregation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ED4.10.2.2e embryogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-10-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG6 cell-cell interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZU10.8.4e retinoic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZU10-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm#ZU10-8-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-6">ED4.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>conception and pregnancy&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-8">ED4.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>conception&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> biological conception </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ES2e fertility &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ES2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ES2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-8-2">ED4.8.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sperm capacitation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-8-4">ED4.8.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>fertilization&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> zygote formation </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ES4.2.6.2e sperm &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ES4-2-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ES4-2-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XQ4.2.4e ovum &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XQ4-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XQ4-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10">ED4.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>prenatal development&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The entire process of growth, maturation, differentiation, and development that occurs between conception and birth.  The weeks given in the scope notes for the stages of prenatal development are
   based on the human gestational process.  These descriptors still can be used for animal prenatal development.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EM2.2 fetal breathing movements &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EM2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#EM2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GJ2.4 poor fetal development &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ED4.12e pregnancy &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ED4.16e gestation stage &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ESe reproductive function &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ES"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ES"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GJ2e intrauterine disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XEe fetoplacental anatomy &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XE"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XE"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2">ED4.10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>embryologic development&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="31%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The various intrauterine stages and processes involved in the growth and differentiation of the conceptus from the time of fertilization until the eighth week of gestation.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>XX2.4.4.2e radial glia &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XX2-4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxv.htm#XX2-4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ED4.16.2e first trimester &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-16-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-16-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-2">ED4.10.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>embryogenesis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The formation of the embryo during the 10 days to 2 weeks after fertilization until implantation.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> redifferentiation period </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+XE2.2e embryo &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XE2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XE2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ED4e biological development &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ED4.4.2 morphogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GJ2.16.2.4e alcohol-related intrauterine disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-16-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-16-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-2-2">ED4.10.2.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>zygote&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">ST</TD><TD> fertilized egg </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> fertilized ovum </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ED4.10.2.2.6 cleavage &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-10-2-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-2-4">ED4.10.2.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>primordium&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">ST</TD><TD> anlage </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+Xe body part &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#X"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#X"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-2-6">ED4.10.2.2.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>cleavage&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">ST</TD><TD> cytokinesis </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> merogenesis </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ED4.10.2.2.2 zygote &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-10-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-2-6-2">ED4.10.2.2.6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>blastula&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="37%"> </TD><TD WIDTH="5%">ST</TD><TD> blastosphere </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> blastula stage </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-2-8">ED4.10.2.2.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>gastrulation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">RT</TD><TD>+ED4.4 biological differentiation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ED4.14e pregnancy outcome &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-2-8-2">ED4.10.2.2.8.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>gastrula&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="37%"> </TD><TD WIDTH="5%">ST</TD><TD> invaginate planula </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-4">ED4.10.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>organogenesis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The differentiation of the various cells, tissues, and organ systems and the development of the main external features of the embryo; it occurs approximately from the end of the second week to the
   eighth week of intrauterine life.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> embryonic period </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ED4.4 biological differentiation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EG2e cell growth and differentiation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG2.8e cell migration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG2-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-4-2">ED4.10.2.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>placentation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The structural organization and mode of attachment of fetal to maternal tissues in the formation of the placenta.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> amniotic membrane development </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> placental development </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>XE4e placenta &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XE4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XE4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-4-2-2">ED4.10.2.4.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>zygote implantation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-2-4-4">ED4.10.2.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sexual differentiation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="35%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>During organogenesis, the development of the fetus into male versus female.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-10-4">ED4.10.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>fetal development&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The development of the fetus from 8 weeks to delivery.  During this period, exposure to alcohol generally does not cause gross structural deformations but can produce subtle changes in the fetus to
   the CNS and other organ systems.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> fetal period </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> fetal stage </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> fetogenesis </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ED4e biological development &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GJ2.16e chemical intrauterine disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XX2.2.4.14e neural crest cell &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XX2-2-4-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxv.htm#XX2-2-4-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-12">ED4.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pregnancy&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 2000; through 1999 use "gestation."
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The condition of a female after conception until the birth of the baby.  The descriptor pregnancy is used when the emphasis is on the expectant mother, the descriptor *+ED4.10 prenatal development*
   <A HREF="aodhqe.htm#ED4-10"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#ED4-10"><SMALL>ah</SMALL></A> is used when the emphasis is on the development of the embryo/fetus.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> gestation </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> gravidity </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ED4.16e gestation stage &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE20.6e prenatal chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GJ2.14.2 chemical teratogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GJ2.16.2 AODR intrauterine disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-16-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-16-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>LK2.6 pregnancy as a life event &nbsp;&nbsp;&nbsp;<A HREF="aodhql.htm#LK2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnlh.htm#LK2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TE10.2 pregnant female &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TE10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TE10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YG18e pregnancy hormones &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YG18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YG18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-14">ED4.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pregnancy outcome&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 2000; through 1999 use "gestation outcome."  ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> gestation outcome </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>GJ2.8e miscarriage &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GJ2.10e stillbirth &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>HV10e abortion &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HV10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HV10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ED4.10.2.2.8 gastrulation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-10-2-2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GJ2.12e low birth weight &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-14-2">ED4.14.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>childbirth&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-14-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 2000; through 1999 use "parturition."  ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> labor (parturition) </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> parturition </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>LJ2e birth &nbsp;&nbsp;&nbsp;<A HREF="aodhql.htm#LJ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnlh.htm#LJ2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TA10e perinatal &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TA10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TA10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-14-2-2">ED4.14.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>premature birth&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-14-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> preterm delivery </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+JA6.12.6 biological risk and protective factors &nbsp;&nbsp;&nbsp;<A HREF="aodhqj.htm#JA6-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnj.htm#JA6-12-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-14-2-4">ED4.14.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>postpartum&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-14-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 2000; through 1999 use "puerperium."  ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="33%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The period following the third stage of labor, lasting until the involution of pelvic organs takes place; usually 3 to 6 weeks.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> puerperium </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-16">ED4.16</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>gestation stage&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 2000; through 1999 use "human gestation stage."  ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>If the emphasis is on the embryo/fetus then combine with *+ED4.10 prenatal development* <A HREF="aodhqe.htm#ED4-10"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#ED4-10"><SMALL>ah</SMALL></A> or one of
   its narrower terms; if the emphasis is on the mother then combine with *ED4.12 pregnancy* <A HREF="aodhqe.htm#ED4-12"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#ED4-12"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> gestation phases </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> phases of the prenatal period </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> stage of pregnancy </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> stage of prenatal development </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>GA10.8.2.2e fetal vulnerability &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GA10-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GA10-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GA10.8.2.4e fetal sensitivity &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GA10-8-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GA10-8-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TA8e prenatal &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TA8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TA8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-16-2">ED4.16.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>first trimester&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-16-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+ED4.10.2e embryologic development &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-16-4">ED4.16.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>second trimester&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-16-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED4-16-6">ED4.16.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>third trimester&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-16-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+TA10e perinatal &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TA10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TA10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6">ED6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>biological life cycle&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>EG2.2.2 cell cycle &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+LJe stage of life &nbsp;&nbsp;&nbsp;<A HREF="aodhql.htm#LJ"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnlh.htm#LJ"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6-2">ED6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biological maturation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD>+ED4e biological development &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6-2-2">ED6.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biological immaturity&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> juvenile </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+LJ6.2e childhood &nbsp;&nbsp;&nbsp;<A HREF="aodhql.htm#LJ6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnlh.htm#LJ6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6-2-4">ED6.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biological maturity&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">RT</TD><TD>+LJ8e adulthood &nbsp;&nbsp;&nbsp;<A HREF="aodhql.htm#LJ8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnlh.htm#LJ8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6-2-6">ED6.2.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sexual maturity&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> sexual maturation </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ESe reproductive function &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ES"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ES"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+LJ8e adulthood &nbsp;&nbsp;&nbsp;<A HREF="aodhql.htm#LJ8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnlh.htm#LJ8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6-2-6-2">ED6.2.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>puberty&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-2-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ES14e menarche &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ES14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ES14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>LJ6.4e adolescence &nbsp;&nbsp;&nbsp;<A HREF="aodhql.htm#LJ6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnlh.htm#LJ6-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6-4">ED6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>aging&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>GJ6.10 premature aging &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ6-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ6-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>LJ8.6 old age &nbsp;&nbsp;&nbsp;<A HREF="aodhql.htm#LJ8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnlh.htm#LJ8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TA16.6e elderly &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TA16-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TA16-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6-4-2">ED6.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>senescence&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6-4-4">ED6.4.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biological involution&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">RT</TD><TD>+EG2e cell growth and differentiation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6-6">ED6.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biological death&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD>+EG2.6.6e cytolysis &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG2-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>LJ10e death &nbsp;&nbsp;&nbsp;<A HREF="aodhql.htm#LJ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnlh.htm#LJ10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+PB6.12e mortality &nbsp;&nbsp;&nbsp;<A HREF="aodhqpa.htm#PB6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnpa.htm#PB6-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ED6-8">ED6.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biological longevity&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>PB6.2e life expectancy &nbsp;&nbsp;&nbsp;<A HREF="aodhqpa.htm#PB6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnpa.htm#PB6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE"><B><BIG>EE</BIG></B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>pharmacology and toxicology</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#EE"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The word "drug" throughout *+EE pharmacology and toxicology* <A HREF="aodhqe.htm#EE"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#EE"><SMALL>ah</SMALL></A> refers to any chemical substance, including
   medications, alcohol and other drugs, toxins, nutrients, and other substances.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EA4e biochemical mechanism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EA4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EA4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EBe metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+HRe drug therapy &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HR"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HR"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+SE4 pharmacology (field) &nbsp;&nbsp;&nbsp;<A HREF="aodhqs.htm#SE4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhns.htm#SE4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE2"><B>EE2</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>AOD abuse and dependence potential</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EE18.2 drug evaluation criteria &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE18-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE2-2">EE2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>AOD abuse potential&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The propensity of a particular psychoactive substance to be susceptible to abuse.  This term refers to the relative probability that a drug will result in social, psychological, or physical problems
   in an individual or in society.  
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> AOD abuse liability </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+GC2e AOD abuse &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GC2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GC2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>GC16.2 alcohol abuse &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GC16-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GC16-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE2-4">EE2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>AOD dependence potential&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The propensity of a substance, by its pharmacological effects on physiological or psychological functions, to increase the likelihood of dependence on that substance.  Dependence potential is
   determined by those intrinsic pharmacological properties that can be measured in animal and human drug-testing procedures.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> AOD dependence liability </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>BA8 habit-forming drug &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BA8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BA8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GC6e AOD dependence &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GC6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GC6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GC16.6 alcohol dependence &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GC16-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GC16-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE4"><B>EE4</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>drug purity</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>MN28.2.8.2.2 drug purity regulation &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MN28-2-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmn.htm#MN28-2-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+OA6 product quality &nbsp;&nbsp;&nbsp;<A HREF="aodhqo.htm#OA6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhno.htm#OA6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EE18.2 drug evaluation criteria &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE18-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE6"><B>EE6</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>administrative drug regulation</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+MN28.2 manufactured product regulation &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MN28-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmn.htm#MN28-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE6-2">EE6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug nomenclature&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>MN28.2.8.2.2 drug purity regulation &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MN28-2-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmn.htm#MN28-2-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE6-4">EE6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug recall&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>MN28.2.8.2.2 drug purity regulation &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MN28-2-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmn.htm#MN28-2-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE6-6">EE6.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug scheduling&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The process in which controlled drugs are commonly classified on a hierarchy of schedules that reflect different degrees of restriction of availability.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BT6e controlled substance &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>JU12.4.2 pharmacy drug and narcotic control &nbsp;&nbsp;&nbsp;<A HREF="aodhqj.htm#JU12-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnjq.htm#JU12-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+MM20.10.6.4 drug diversion &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MM20-10-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmm.htm#MM20-10-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+MN20.12.4 drug distribution laws &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MN20-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmn.htm#MN20-12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>MN20.12.4.2 laws on dispensing pharmaceuticals &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MN20-12-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmn.htm#MN20-12-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>MP18.4 public policy on pharmaceuticals &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MP18-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmp.htm#MP18-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE8"><B>EE8</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>generic and proprietary drug</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE8-2">EE8.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>generic drug&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE8-4">EE8.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>proprietary drug&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE10"><B>EE10</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>drug by legal status</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BT AOD substance by legal status &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE10-2">EE10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>over-the-counter drug&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Drugs that may be purchased without prescription.  There are an estimated 350,000 OTC products with annual sales of $4 billion to $5 billion (Inhorn 1981).  OTC drugs are subject to abuse,
   particularly certain cough remedies that contain potent analgesic/euphoric or hallucinogenic substances.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> nonprescription drug </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> OTC drug </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> pharmaceutical drug </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>SG16.18 pharmaceutical industry &nbsp;&nbsp;&nbsp;<A HREF="aodhqs.htm#SG16-18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhns.htm#SG16-18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE10-4">EE10.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>prescription drug&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE10-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>AA2.4.4.2 nonprescribed use of drug &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AA2-4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AA2-4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GC2.6 abuse of non-dependence-producing substance &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GC2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GC2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+MM20.10.6.4 drug diversion &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MM20-10-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmm.htm#MM20-10-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>SG16.18 pharmaceutical industry &nbsp;&nbsp;&nbsp;<A HREF="aodhqs.htm#SG16-18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhns.htm#SG16-18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12"><B>EE12</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>pharmacokinetics</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The distribution and concentration of drugs in the various tissues of the body as influenced by absorption, tissue distribution, metabolism, and elimination by excretion. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Combine with descriptors from *+X body part* <A HREF="aodhqx.htm#X"><SMALL>qh</SMALL></A> <A HREF="aodhnx.htm#X"><SMALL>ah</SMALL></A> (e.g., *+XC4 body
   space* <A HREF="aodhqx.htm#XC4"><SMALL>qh</SMALL></A> <A HREF="aodhnx.htm#XC4"><SMALL>ah</SMALL></A>, *+XB4 tissue* <A HREF="aodhqx.htm#XB4"><SMALL>qh</SMALL></A> <A
   HREF="aodhnx.htm#XB4"><SMALL>ah</SMALL></A>, *+XF body system or organ* <A HREF="aodhqx.htm#XF"><SMALL>qh</SMALL></A> <A HREF="aodhnxf.htm#XF"><SMALL>ah</SMALL></A>), as appropriate.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The word "drug" in this section refers to any chemical substance, including medications, alcohol and other drugs, toxins, nutrients, and other substances.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+EB10e drug metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EFe route of administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>AE4.4 biological AOD tolerance &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AE4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AE4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>CK2.4e structure activity relationship &nbsp;&nbsp;&nbsp;<A HREF="aodhqc.htm#CK2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnc.htm#CK2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE16e drug interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+HRe drug therapy &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HR"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HR"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-2">EE12.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug absorption&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD>+EFe route of administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EP2.12e gastrointestinal absorption &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EP2-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#EP2-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XK2.2.2 nasal membrane &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XK2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XK2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XM2.2.4.4e gastric mucosa &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XM2-2-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XM2-2-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XM2.4.4e intestinal mucosa &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XM2-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XM2-4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4">EE12.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug distribution (pharmacokinetics)&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD>+XC4 body space &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XC4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XC4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4-2">EE12.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug transfer across body barrier&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+EC2e biological transport &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EC2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EC2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+XC6 body barrier &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XC6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XC6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4-2-2">EE12.4.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>blood-brain drug transfer&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4-2-4">EE12.4.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>placental drug transfer&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EE20.6e prenatal chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XE4e placenta &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XE4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XE4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4-4">EE12.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug binding&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+EA4e biochemical mechanism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EA4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EA4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>CK2.4e structure activity relationship &nbsp;&nbsp;&nbsp;<A HREF="aodhqc.htm#CK2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnc.htm#CK2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE12.4.4.2.2 protein-bound drug fraction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE12-4-4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EG14.2e receptor ligand binding &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZO6.4.10e blood proteins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-4-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4-4-2">EE12.4.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug binding measure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4-4-2-2">EE12.4.4.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>protein-bound drug fraction&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> bound drug </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EE12.4.4e drug binding &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE12-4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4-4-2-4">EE12.4.4.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>free drug fraction&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-4-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> free drug </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> unbound plasma drug fraction (fp) </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4-6">EE12.4.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug distribution measure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4-6-2">EE12.4.6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug distribution volume&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> Vd </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE14.2.2 drug loading dose &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-4-6-4">EE12.4.6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug partition coefficient&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6">EE12.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug disposition&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-2">EE12.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug concentration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EE14.2e drug dose &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-2-2">EE12.6.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug steady state concentration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-2-4">EE12.6.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>blood drug concentration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD>+HB2.8e BAC &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HB2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HB2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+XSe blood &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XS"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxr.htm#XS"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-2-4-2">EE12.6.2.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>serum drug concentration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-2-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>XS10e serum &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XS10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxr.htm#XS10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-2-4-4">EE12.6.2.4.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>plasma drug concentration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-2-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>XS8e plasma &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XS8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxr.htm#XS8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-4">EE12.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>bioavailability&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The degree of activity or the amount of an administered drug or other substance that becomes available for activity in the target tissue.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-6">EE12.6.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug reservoir&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD>+XB4.2.10e adipose tissue &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XB4-2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XB4-2-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XB4.2.16e bone &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XB4-2-16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XB4-2-16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZO6.4.10.4e plasma proteins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-4-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-4-10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-8">EE12.6.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug retention&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+GR20.12 fluid overload &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GR20-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngo.htm#GR20-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-10">EE12.6.10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug accumulation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-12">EE12.6.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug clearance&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> drug extraction </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+EB10e drug metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EB10.10e drug excretion &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB10-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB10-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE14.2.4 drug maintenance dose &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+OD2e AOD production process &nbsp;&nbsp;&nbsp;<A HREF="aodhqo.htm#OD2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhno.htm#OD2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-12-2">EE12.6.12.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug clearance rate&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-12-2-4">EE12.6.12.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>whole body drug clearance&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-12-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The sum of the individual clearances of a substance by the various organs and tissues of the body.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> total drug clearance </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-12-2-6">EE12.6.12.2.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>regional drug clearance&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-12-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-12-2-6-2">EE12.6.12.2.6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>renal drug clearance&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-12-2-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">BT</TD><TD>+EB10.10e drug excretion &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB10-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB10-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ER2e kidney function &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ER2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ER2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-12-2-6-4">EE12.6.12.2.6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>hepatic drug clearance&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-12-2-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">ST</TD><TD> hepatic drug extraction </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EB10e drug metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EP6e liver function &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EP6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#EP6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XM6e liver &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XM6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XM6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE12-6-12-2-6-4-2">EE12.6.12.2.6.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>hepatic first pass effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-12-2-6-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="37%"> </TD><TD WIDTH="5%">ST</TD><TD> presystemic drug clearance </TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14"><B>EE14</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>pharmacodynamics</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The study of the biochemical and physiological effects of drugs and their mechanisms of action.  The objectives of the analysis of drug action are to identify the primary action (as distinguished
   from describing resultant effects), to delineate the chemical or physical interactions between drug and cell, and to characterize the full sequence and scope of actions and effects.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The word "drug" in this section refers to any chemical substance, including medications, alcohol and other drugs, toxins, nutrients, and other substances.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> drug dose and effect </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+EE16e drug interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EE18.2 drug evaluation criteria &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE18-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE20.6e prenatal chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-2">EE14.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug dose&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>AD12.4e AOD intake per occasion &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AD12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AD12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+AD12e amount of AOD use &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AD12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AD12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE12.6.2e drug concentration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE12-6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-2-2">EE14.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug loading dose&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>EE12.4.6.2 drug distribution volume &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE12-4-6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-2-4">EE14.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug maintenance dose&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD>+EE12.6.12e drug clearance &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE12-6-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-2-6">EE14.2.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug monitoring&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Use only for the periodic measurement of drug (therapeutic or other) levels in patients (e.g., the measurement of blood alcohol in alcoholics undergoing treatment or the measurement of therapeutic
   drugs to monitor compliance with treatment or to prevent toxic effects).  For measuring drug levels in population groups for the purpose of detecting psychoactive drug usage, use *+JG26.2.4.2
   identification and screening for AOD use* <A HREF="aodhqj.htm#JG26-2-4-2"><SMALL>qh</SMALL></A> <A HREF="aodhnjg.htm#JG26-2-4-2"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+GCe AODD &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GC"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GC"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4">EE14.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Refers to the pharmacological effects of drugs.  If the biochemical mechanism for the effect is discussed, combine with a descriptor from  *+EA4 biochemical mechanism* <A
   HREF="aodhqe.htm#EA4"><SMALL>qh</SMALL></A> <A HREF="aodhne.htm#EA4"><SMALL>ah</SMALL></A>, *+EB metabolism* <A HREF="aodhqe.htm#EB"><SMALL>qh</SMALL></A> <A
   HREF="aodhne.htm#EB"><SMALL>ah</SMALL></A>, or *+EA8 biological regulation* <A HREF="aodhqe.htm#EA8"><SMALL>qh</SMALL></A> <A HREF="aodhne.htm#EA8"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> drug response </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+AM2e AODE &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AM2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AM2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+AMe AOD effects and consequences &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AM"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AM"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EA22.2e biological adaptation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EA22-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EA22-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EB10e drug metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>FK8.4.2e drug discrimination &nbsp;&nbsp;&nbsp;<A HREF="aodhqf.htm#FK8-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnff.htm#FK8-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GDe AODR disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GD"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GD"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GD4 alcohol related disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GD4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GD4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+Xe body part &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#X"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#X"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-2">EE14.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug efficacy&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The ability of a drug to safely produce a desired or claimed treatment result.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EE14.6.2e dose-response relationship &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE18.2 drug evaluation criteria &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE18-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE18.2.2 drug safety &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE18-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-4">EE14.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>beneficial vs adverse drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> drug risk-to-benefit ratio </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>AD12.14.2 moderate drinking &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AD12-14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AD12-14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ALe AOD effects and AODR problems &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AL"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AL"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+AM2e AODE &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AM2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AM2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+JA6 risk and protective factors &nbsp;&nbsp;&nbsp;<A HREF="aodhqj.htm#JA6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnj.htm#JA6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+MK12.2 social costs and benefits of AOD &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MK12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnm.htm#MK12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+MT10.4.6e risk-benefit analysis &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MT10-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmt.htm#MT10-4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-4-2">EE14.4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>therapeutic drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> beneficial drug effect </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>BE8e medical use of marijuana &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BE8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BE8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YNe therapeutic agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YN"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YN"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-4-2-2">EE14.4.4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>protective drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.  ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+JA6.8e protective factors &nbsp;&nbsp;&nbsp;<A HREF="aodhqj.htm#JA6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnj.htm#JA6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+AD12.14e moderate AOD use &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AD12-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AD12-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-4-4">EE14.4.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>adverse drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>In the general medical and pharmacological fields, adverse drug reaction denotes a toxic physical or (less commonly) psychological reaction to a therapeutic agent.  The reaction may be predictable,
   or it may be an allergic or idiosyncratic (nonpredictable) one. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the substance abuse field, this term includes unpleasant psychological or physical reactions to taking drugs.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> adverse drug event </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> side effect (drug) </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+JP12.12 treatment side effects &nbsp;&nbsp;&nbsp;<A HREF="aodhqj.htm#JP12-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnjl.htm#JP12-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+AA2.4e problematic AOD use &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AA2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AA2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+AA2.4.4 AOD misuse &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AA2-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AA2-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE16e drug interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE16.8e adverse drug interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE16-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GC2.4 harmful AOD use &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GC2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GC2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GH10.4 chemical poisoning &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GH10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GH10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GJ6e growth and development disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-4-4-2">EE14.4.4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>toxic drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Use for discussions of specific adverse effects.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> toxicity </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE16.8e adverse drug interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE16-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE18.2.2 drug safety &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE18-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GDe AODR disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GD"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GD"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GH10.4 chemical poisoning &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GH10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GH10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GJ2.14.2 chemical teratogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GU2 immediate hypersensitivity &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GU2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngu.htm#GU2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-4-4-2-2">EE14.4.4.4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>hepatotoxicity&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="35%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The tendency of an agent, usually alcohol or other drug, to have a destructive effect on the liver.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EP6e liver function &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EP6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#EP6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-4-4-2-4">EE14.4.4.4.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>neurotoxicity&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="35%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The ability of a drug or other agent to destroy or damage nervous tissue.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+XX4e neural tissue &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XX4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxv.htm#XX4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YX2.14e neurotoxins &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX2-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-4-4-2-6">EE14.4.4.4.2.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug toxicity potential&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Measurement of potential toxicity.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EE14.4.4.4.2.10 delayed toxicity &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4-2-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE14.6.6.6 median lethal dose &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-6-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-6-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EE18.2 drug evaluation criteria &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE18-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE14.4.6.10.2 cumulative drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-6-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GH10.4 chemical poisoning &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GH10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GH10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>HF20.12 immunologic cytotoxicity test &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HF20-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HF20-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-4-4-2-8">EE14.4.4.4.2.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>irreversible toxic effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>GG20.28.2e carcinogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GG20-28-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GG20-28-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GJ2.14e teratogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-4-4-2-10">EE14.4.4.4.2.10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>delayed toxicity&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">BT</TD><TD>+EE14.4.4.4.2.6e drug toxicity potential &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14.4.6 drug effect by time &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE14.4.6.2 drug latency &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GH10.4 chemical poisoning &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GH10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GH10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-6">EE14.4.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug effect by time&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>EE14.4.4.4.2.10 delayed toxicity &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4-2-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>AE4.4 biological AOD tolerance &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AE4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AE4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+AMe AOD effects and consequences &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AM"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AM"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+AM2e AODE &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AM2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AM2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE20e chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-6-2">EE14.4.6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug latency&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+EE18.2 drug evaluation criteria &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE18-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE14.4.4.4.2.10 delayed toxicity &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4-2-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-6-4">EE14.4.6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug peak effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-6-6">EE14.4.6.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>acute drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Effects of a single drug dose upon the user (includes animals used in laboratory testing).
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> short-term drug effect </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>AM2.6e acute AODE &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AM2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AM2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>AD14.4 short-term AOD use &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AD14-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AD14-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE20e chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-6-6-2">EE14.4.6.6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>subacute drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Effects appearing after the immediate effects of a single dose disappear.  Intermediate in character between acute and chronic.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EE20e chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-6-8">EE14.4.6.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>chronic drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Effects appearing with long-term, frequent drug use (includes animals used in laboratory testing).
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> long-term drug effect </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>AM2.8e chronic AODE &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AM2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AM2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>AD14.6 long-term AOD use &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AD14-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AD14-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE20e chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-6-10">EE14.4.6.10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>persistent drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Effects persisting beyond the normal time period during which a drug (possibly a single dose) acts (e.g., a persistent hallucinosis).
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EE20e chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-6-10-2">EE14.4.6.10.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>cumulative drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">RT</TD><TD>+EE14.4.4.4.2.6e drug toxicity potential &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE20e chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-8">EE14.4.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug effect by location&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD>+EFe route of administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+Xe body part &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#X"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#X"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-8-2">EE14.4.8.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>local drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">RT</TD><TD>+EF2.2 topical and local administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-4-8-4">EE14.4.8.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>systemic drug effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">RT</TD><TD>+EF2.4 systemic administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-6">EE14.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>relationship between dose and effect&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The variation in intensity and character of response as the dosage of the same drug is varied (<I>dose response relationship</I>) as well as the dose needed to achieve a given effect, as compared
   between two or more drugs (*+EE14.6.6 drug potency* <A HREF="aodhqe.htm#EE14-6-6"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#EE14-6-6"><SMALL>ah</SMALL></A>).
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-6-2">EE14.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dose-response relationship&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 1995; through 1995 also use "dose-effect relationship."
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The variation in intensity and character of response as the dosage of the same drug is varied.  The observed relationship frequently is plotted with the dosage level on one axis and the response
   level on the other, resulting in a dose-response curve.  The relationship may be direct (as the dosage increases, the response level increases) or biphasic (as the dosage increases, the response
   level first increases, then decreases).  Low doses of alcohol, for example, may have a disinhibiting, enervating effect, but as the dosage increases, this effect may be reversed into an inhibiting,
   stuporous effect.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> dose-effect curve </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> dose-effect relationship </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> dose-response curve </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> serum drug concentration response relationship </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EE14.4.2e drug efficacy &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+JP14e treatment outcome &nbsp;&nbsp;&nbsp;<A HREF="aodhqj.htm#JP14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnjl.htm#JP14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-6-4">EE14.6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>effective drug concentration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> therapeutic drug concentration </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-6-6">EE14.6.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug potency&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A measure to compare drugs that achieve a given effect.  The lower the dose needed to produce an effect of a given size, the more potent the drug.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A relative term to compare the amounts of two or more drugs required to produce a given effect; the more potent the drug, the less is required.  The same
   effect can be achieved by more of a less potent substance or by less of the same substance in a more potent form.  Occasionally the term is used to refer to the length or duration of effects.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-6-6-4">EE14.6.6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>median effective dose&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-6-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> median effective serum concentration </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE14-6-6-6">EE14.6.6.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>median lethal dose&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-6-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+EE14.4.4.4.2.6e drug toxicity potential &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE16"><B>EE16</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>drug interaction</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">ST</TD><TD> drug-drug interaction </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EE14e pharmacodynamics &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>AA2.6e multiple drug use &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AA2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AA2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+CJe chemistry &nbsp;&nbsp;&nbsp;<A HREF="aodhqc.htm#CJ"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnc.htm#CJ"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EBe metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE12e pharmacokinetics &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14.4.4.4e adverse drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE16-2">EE16.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>additive drug interaction&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The action obtained when the combined effect of two or more drugs taken together is equal to the sum of the individual effects.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> additive drug effects </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE16-4">EE16.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>synergistic drug interaction&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The joint action of two or more drugs that results in a total effect greater than the sum of the individual effects.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> drug potentiation </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> supra-additive drug interactions </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> synergistic drug effects </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>YL2.2 ethanol agonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV14.2e adrenergic receptor agonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV14-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE16-6">EE16.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>antagonistic drug interaction&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">ST</TD><TD> antagonistic drug effects </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YD8e enzyme inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YD8.2 ADH antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YG34 hormone antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YG34"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YG34"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YL2.4 ethanol antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YL6e antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YM14.2 prostaglandin antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YM14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT14.2e anticoagulants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT14.6.4 heparin antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT14-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT14-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.4e histamine antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6e serotonin antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YV14.4e neurotransmitter uptake inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV14-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV14-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW12.2e narcotic antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE16-8">EE16.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>adverse drug interaction&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD>+EE14.4.4.4e adverse drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14.4.4.4.2e toxic drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GH10.4 chemical poisoning &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GH10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GH10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE18"><B>EE18</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>drug evaluation</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The evaluation of a drug's effectiveness, safety, and so forth.  Do not confuse this with testing a person for drug use, which is *+HB AODU screening, identification, and diagnostic method* <A
   HREF="aodhqha.htm#HB"><SMALL>qh</SMALL></A> <A HREF="aodhnha.htm#HB"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> testing of a drug </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+FV22e evaluation &nbsp;&nbsp;&nbsp;<A HREF="aodhqf.htm#FV22"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnfr.htm#FV22"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+MN28.2.8.2 pure food and drug laws &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MN28-2-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmn.htm#MN28-2-8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE18-2">EE18.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug evaluation criteria&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EE14.4.2e drug efficacy &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14.4.4.4.2.6e drug toxicity potential &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE14.4.6.2 drug latency &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EE2 AOD abuse and dependence potential &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE4e drug purity &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14e pharmacodynamics &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+MQ8.4.2e cost-benefit analysis &nbsp;&nbsp;&nbsp;<A HREF="aodhqm.htm#MQ8-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnmq.htm#MQ8-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE18-2-2">EE18.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug safety&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>EE14.4.2e drug efficacy &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14.4.4.4.2e toxic drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE18-4">EE18.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug evaluation process&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> drug evaluation procedures </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE18-4-2">EE18.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>drug effect measurement&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE18-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20"><B>EE20</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>chemical exposure</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Passive or involuntary exposure to chemical substances.  Use for documents that discuss exposure (e.g., prevalence of exposure) and exposure mechanisms, with or without a discussion of effects.  If
   applicable, use the appropriate descriptor from *+TA age* <A HREF="aodhqt.htm#TA"><SMALL>qh</SMALL></A> <A HREF="aodhnt.htm#TA"><SMALL>ah</SMALL></A> and from *+B AOD substance or product* <A
   HREF="aodhqb.htm#B"><SMALL>qh</SMALL></A> <A HREF="aodhnb.htm#B"><SMALL>ah</SMALL></A>.  For documents that discuss the effects of chemical exposure, use *+GH10 exogenous chemical disorder* <A
   HREF="aodhqg.htm#GH10"><SMALL>qh</SMALL></A> <A HREF="aodhngf.htm#GH10"><SMALL>ah</SMALL></A>, if appropriate, in conjunction with *+EE20 chemical exposure* <A
   HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#EE20"><SMALL>ah</SMALL></A>.  Do not use *+EE20 chemical exposure* <A HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A> <A
   HREF="aodhned.htm#EE20"><SMALL>ah</SMALL></A> if mention of exposure is merely incidental to the discussion of effects.  For a complete search, combine both descriptors with OR.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+Be AOD substance or product &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#B"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#B"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14.4.6 drug effect by time &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14.4.6.6 acute drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE14.4.6.6.2 subacute drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14.4.6.8 chronic drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14.4.6.10 persistent drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-6-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE14.4.6.10.2 cumulative drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-6-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-6-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EFe route of administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GH10 exogenous chemical disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GH10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GH10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+PZ2 physical environment &nbsp;&nbsp;&nbsp;<A HREF="aodhqpm.htm#PZ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnpm.htm#PZ2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TL6.2.6e postnatally AOD-exposed child &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TL6-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TL6-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-2">EE20.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>passive inhalation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">ST</TD><TD> passive smoking </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>BD6.2 secondhand smoke &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BD6 tobacco smoke &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE20.8 postnatal chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EF4.4.4.2e smoking &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-4">EE20.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>reproductive effects of AODU&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The effects of AODU on the reproductive system and consequential effects on offspring as opposed to the direct AOD effects on the fetus, which is covered in *+EE20.6.4 prenatal AOD exposure* <A
   HREF="aodhqe.htm#EE20-6-4"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#EE20-6-4"><SMALL>ah</SMALL></A> and *+GJ2.16.2 AODR intrauterine disorder* <A HREF="aodhqg.htm#GJ2-16-2"><SMALL>qh</SMALL></A>
   <A HREF="aodhngj.htm#GJ2-16-2"><SMALL>ah</SMALL></A>.  This concept is classified here because the focus is on the effects on offspring.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+AM2.2e physiological AODE &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AM2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AM2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XQe reproductive system &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XQ"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XQ"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-4-2">EE20.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>maternal AOD exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-4-2-2">EE20.4.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>maternal alcohol exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BBe alcohol in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BB"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BB"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>GJ2.16.2.4.2e fetal alcohol effects &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-16-2-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-16-2-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-4-4">EE20.4.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>paternal AOD exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-4-4-2">EE20.4.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>paternal alcohol exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BBe alcohol in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BB"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BB"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>GJ2.16.2.4.2e fetal alcohol effects &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-16-2-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-16-2-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-6">EE20.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>prenatal chemical exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Use this descriptor when the mechanism of exposure is discussed.  Use *+GJ2.16 chemical intrauterine disorder* <A HREF="aodhqg.htm#GJ2-16"><SMALL>qh</SMALL></A> <A
   HREF="aodhngj.htm#GJ2-16"><SMALL>ah</SMALL></A> when the actual effects due to drug exposure are discussed.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> embryonal chemical exposure </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> fetal chemical exposure </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> in utero chemical exposure </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF4.6e parenteral administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ED4.12e pregnancy &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE12.4.2.4e placental drug transfer &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE12-4-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14e pharmacodynamics &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GJ2.14e teratogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GJ2.14.2 chemical teratogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GJ2.16e chemical intrauterine disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GJ2.16.2.2.2 neonatal abstinence syndrome &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-16-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-16-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TE10.2 pregnant female &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TE10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TE10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TL6e AOD-exposed &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TL6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TL6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-6-2">EE20.6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>timing of prenatal chemical exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> timing of in utero chemical exposure </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-6-4">EE20.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>prenatal AOD exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.  ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> intrauterine AOD exposure </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>AA2.8e involuntary AOD use &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AA2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AA2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE20.4e reproductive effects of AODU &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+JA6.12.6 biological risk and protective factors &nbsp;&nbsp;&nbsp;<A HREF="aodhqj.htm#JA6-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnj.htm#JA6-12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TL6e AOD-exposed &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TL6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TL6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-6-4-2">EE20.6.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>prenatal alcohol exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-6-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Use this descriptor when the mechanism of exposure is discussed.  Use *GJ2.16.2.4.2 fetal alcohol effects* <A HREF="aodhqg.htm#GJ2-16-2-4-2"><SMALL>qh</SMALL></A> <A
   HREF="aodhngj.htm#GJ2-16-2-4-2"><SMALL>ah</SMALL></A> when the actual effects due to exposure to alcohol are discussed.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BBe alcohol in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BB"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BB"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>GJ2.16.2.4.2e fetal alcohol effects &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-16-2-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-16-2-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GJ2.16.2.4.6e fetal alcohol syndrome &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-16-2-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-16-2-4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-6-4-4">EE20.6.4.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>prenatal cocaine exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-6-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+BK cocaine in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BK"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BK"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BK2e cocaine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BK2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BK2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-8">EE20.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>postnatal chemical exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Exposure of an infant (0 to 12 months) to chemical substances via inhalation or nursing.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> infant chemical exposure </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+TA12.2e infant &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TA12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TA12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EE20.2 passive inhalation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-8-2">EE20.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>postnatal AOD exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> infant AOD exposure </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> postnatal response to AOD exposure </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+Be AOD substance or product &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#B"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#B"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TA12.2e infant &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TA12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TA12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ES24e lactation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ES24"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ES24"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TL6.2.6e postnatally AOD-exposed child &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TL6-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TL6-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EE20-8-2-2">EE20.8.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>postnatal alcohol exposure&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-8-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> infant alcohol exposure </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> postnatal response to alcohol exposure </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BBe alcohol in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BB"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BB"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+TA12.2e infant &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TA12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TA12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+TL6.2.6e postnatally AOD-exposed child &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TL6-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TL6-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
</TABLE><BR><BR>
<CENTER><A HREF="aodob.htm#E">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ED">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqe.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhne.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><P>classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept </P>
</BODY>
</HTML>
